Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carly Dillen

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
JAMA Dermatology|June 5, 2024
Efficacy and Safety of Abrocitinib in Prurigo Nodularis and Chronic Pruritus of Unknown Origin: A Nonrandomized Controlled TrialShawn G Kwatra, Zachary A Bordeaux, Varsha Parthasarathy, et al.
The Journal of Allergy and Clinical Immunology|August 18, 2023
Reduced SARS-CoV-2 mRNA vaccine immunogenicity and protection in mice with diet-induced obesity and insulin resistanceTimothy R O'Meara, Etsuro Nanishi, Marisa E McGrath, et al.
Msphere|July 10, 2026
Optimizing an avian influenza vaccine using a novel Bacterial Enzymatic Combinatorial Chemistry (BECC) TLR4 adjuvantDevon V Riley, Lauren Baracco, Sayan Das, et al.
Biorxiv : the Preprint Server for Biology|June 30, 2021
Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infectionDavid C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.
The Journal of Investigative Dermatology|October 31, 2021
Cluster Analysis of Circulating Plasma Biomarkers in Prurigo Nodularis Reveals a Distinct Systemic Inflammatory Signature in African AmericansNishadh Sutaria, Martin Prince Alphonse, Melika Marani, et al.
Scientific Reports|May 28, 2021
Transcriptomic analysis of atopic dermatitis in African Americans is characterized by Th2/Th17-centered cutaneous immune activationShannon Wongvibulsin, Nishadh Sutaria, Suraj Kannan, et al.
Nature|February 7, 2022
Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2David C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.
Nature Communications|February 28, 2023
Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variantsJames Logue, Robert M Johnson, Nita Patel, et al.
The Journal of Allergy and Clinical Immunology|February 21, 2017
Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinaseXiao Liu, Tica Pichulik, Olaf-Oliver Wolz, et al.
The Journal of Investigative Dermatology|March 27, 2021
Prurigo Nodularis Is Characterized by Systemic and Cutaneous T Helper 22 Immune PolarizationMicah Belzberg, Martin Prince Alphonse, Isabelle Brown, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
JAMA Dermatology|June 5, 2024
Efficacy and Safety of Abrocitinib in Prurigo Nodularis and Chronic Pruritus of Unknown Origin: A Nonrandomized Controlled TrialShawn G Kwatra, Zachary A Bordeaux, Varsha Parthasarathy, et al.
The Journal of Allergy and Clinical Immunology|August 18, 2023
Reduced SARS-CoV-2 mRNA vaccine immunogenicity and protection in mice with diet-induced obesity and insulin resistanceTimothy R O'Meara, Etsuro Nanishi, Marisa E McGrath, et al.
Msphere|July 10, 2026
Optimizing an avian influenza vaccine using a novel Bacterial Enzymatic Combinatorial Chemistry (BECC) TLR4 adjuvantDevon V Riley, Lauren Baracco, Sayan Das, et al.
Biorxiv : the Preprint Server for Biology|June 30, 2021
Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infectionDavid C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.
The Journal of Investigative Dermatology|October 31, 2021
Cluster Analysis of Circulating Plasma Biomarkers in Prurigo Nodularis Reveals a Distinct Systemic Inflammatory Signature in African AmericansNishadh Sutaria, Martin Prince Alphonse, Melika Marani, et al.
Scientific Reports|May 28, 2021
Transcriptomic analysis of atopic dermatitis in African Americans is characterized by Th2/Th17-centered cutaneous immune activationShannon Wongvibulsin, Nishadh Sutaria, Suraj Kannan, et al.
Nature|February 7, 2022
Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2David C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.
Nature Communications|February 28, 2023
Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variantsJames Logue, Robert M Johnson, Nita Patel, et al.
The Journal of Allergy and Clinical Immunology|February 21, 2017
Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinaseXiao Liu, Tica Pichulik, Olaf-Oliver Wolz, et al.
The Journal of Investigative Dermatology|March 27, 2021
Prurigo Nodularis Is Characterized by Systemic and Cutaneous T Helper 22 Immune PolarizationMicah Belzberg, Martin Prince Alphonse, Isabelle Brown, et al.
Pageof 3